Delivery Order SPE2DB24D1201-SPE2DB25FJBYL

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.71 firm-fixed-price delivery order is for the supply of Lyrica 200 mg capsules with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,659.58 firm fixed-price delivery order is for the provision of 100 mg Lyrica capsules. The contract has an ultimate completion date of January 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,177.02 firm fixed-price delivery order is for the supply of Lyrica 25 mg capsules. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,562,300 units of Lyrica 50 mg capsules. The $3,458.71 firm fixed-price delivery order has a completion date of September 26, 2023 and is not associated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,777.75 delivery order contract is for the supply of Lyrica 25 mg capsules to support military healthcare programs. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,534.92 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract provides a range of pharmaceutical products, including LYRICA 225 MG CAPSULE 90S, to support military healthcare programs. The award has an ultimate completion date of January 7, 2025 and a firm fixed price pricing structure. The contract was not set...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lyrica 75 mg capsules in 90-count bottles. The contract, valued at $1,669.62, was awarded on June 17, 2024 by the Defense Logistics Agency (DLA), with a completion date of June 18, 2024. The contract is a firm-fixed price delivery order, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,076.72 firm fixed price delivery order is for the supply of Lyrica 300 mg capsules. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC enables...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,154.12, provides the Defense Logistics Agency (DLA) with Lyrica 100 mg capsules. The contract is a firm-fixed price delivery order, with a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary...
This federal contract award was made to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,106.27, is for the delivery of Lyrica 225 mg capsules. This is a firm fixed price delivery order contract with a completion date of January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJBYL
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Lyrica 300 mg capsules. The $1,704.62 firm fixed-price delivery order has a completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/19/25, 9:59 AM